Getting some perspective on valuation
PYC capped at $500m+ not yet in clinic and addressable market much smaller than OPT.
OPT capped at ~$400m in phase 3 and huge market opportunity
Opthea shares target raised on trial progress, page-6
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.5¢ |
Change
0.015(3.41%) |
Mkt cap ! $553.9M | |||
| Open | High | Low | Value | Volume |
| 44.0¢ | 45.5¢ | 43.5¢ | $397.7K | 889.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1296 | 47.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 41.0¢ | 1952 | 1 |
View Market Depth
| Last trade - 15.59pm 15/08/2024 (20 minute delay) ? |
| OPT (ASX) Chart |